Get the Stockscreener App
5.03
1.62%
+0.08
SOPHiA Genetics SA stock is currently priced at $5.03, with a 24-hour trading volume of 27,982.
It has seen a +1.62% increased in the last 24 hours and a +2.24% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $4.94 pivot point. If it approaches the $5.07 resistance level, significant changes may occur.
Previous Close:
$4.95
Open:
$4.81
24h Volume:
27,982
Market Cap:
$328.47M
Revenue:
$62.37M
Net Income/Loss:
$-78.98M
P/E Ratio:
-4.123
EPS:
-1.22
Net Cash Flow:
$-57.80M
1W Performance:
+1.41%
1M Performance:
+2.24%
6M Performance:
+25.75%
1Y Performance:
+7.94%
1D Range:
$4.81
$5.06
52W Range:
$2.13
$7.37
SOPHiA Genetics SA Stock (SOPH) Company Profile
Name
SOPHiA Genetics SA
Sector
Industry
Phone
41 21 694 10 60
Address
Rue du Centre 172, Saint-Sulpice
SOPHiA Genetics SA Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
SOPHiA Genetics SA Stock (SOPH) Latest News
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
GlobeNewswire Inc.
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
GlobeNewswire Inc.
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why CrowdStrike Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Benzinga
Oddity Tech Posts Q4 Results, Joins Ross Stores And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
SOPHiA Genetics SA Stock (SOPH) Financials Data
SOPHiA Genetics SA (SOPH) Revenue 2024
SOPH reported a revenue (TTM) of $62.37 million for the quarter ending December 31, 2023, a +31.14% rise year-over-year.
SOPHiA Genetics SA (SOPH) Net Income 2024
SOPH net income (TTM) was -$78.98 million for the quarter ending December 31, 2023, a +9.68% increase year-over-year.
SOPHiA Genetics SA (SOPH) Cash Flow 2024
SOPH recorded a free cash flow (TTM) of -$57.80 million for the quarter ending December 31, 2023, a +28.17% increase year-over-year.
SOPHiA Genetics SA (SOPH) Earnings per Share 2024
SOPH earnings per share (TTM) was -$1.22 for the quarter ending December 31, 2023, a +10.95% growth year-over-year.
About SOPHiA Genetics SA
Sophia Genetics SA, a cloud-based software-as-a-service platform that enables healthcare institutions to get insights from their data. The company offers SOPHiA DDM for solid tumors. Sophia Genetics SA was founded in 2012 and is based in Saint-Sulpice, Switzerland.
1.66%
1.42%
Cap:
|
Volume (24h):